Clustering data with hclust algorithm for Genetic and metabolic characterization of bioengineered human fatty liver tissue with modified SIRT1 expression (Study ST001185)
Reversed phase UNSPECIFIED ION MODE (Analysis AN001969)| Metabolite | Structure | F1 | F2 | F3 | F4 |
|---|---|---|---|---|---|
| Citric acid | ME281761 | 0.22 | 0.92 | 4.98 | NA |
| Arginine | ME281743 | 1.98 | 0.01 | 0.02 | NA |
| Oxoglutaric acid | ME281757 | 1.10 | 0.82 | 0.98 | NA |
| Tryptophan | ME281753 | 1.20 | 0.53 | 1.07 | NA |
| Leucine | ME281748 | 1.25 | 0.59 | 0.91 | NA |
| Methionine | ME281749 | 1.31 | 0.52 | 0.81 | NA |
| Glutamine | ME281763 | 1.68 | 0.44 | 0.21 | NA |
| Tyrosine | ME281750 | 1.45 | 0.39 | 0.70 | NA |
| Valine | ME281744 | 1.49 | 0.41 | 0.62 | NA |
| Histidine | ME281747 | 1.54 | 0.42 | 0.50 | NA |
| Serine | ME281742 | 1.55 | 0.34 | 0.56 | NA |
| Glutamic acid | ME281762 | 0.89 | 0.97 | 1.25 | NA |
| Aspartic acid | ME281740 | 0.82 | 1.20 | 1.16 | NA |
| Lactic acid | ME281767 | 0.77 | 1.27 | 1.20 | NA |
| Lysine | ME281745 | 0.89 | 0.89 | 2.00 | NA |
| Ornithine | ME281751 | 0.48 | 0.81 | 2.06 | NA |
| Glucose-6-phosphate | ME281759 | 0.11 | 2.53 | 0.67 | NA |
| Cis-Aconitic acid | ME281765 | 0.02 | 2.13 | 1.51 | NA |
| Fumaric acid | ME281760 | 0.25 | 2.19 | 1.32 | NA |
| Hexose | ME281755 | 0.34 | 2.04 | 1.29 | NA |
| Itaconic acid | ME281756 | 0.28 | 1.81 | 1.64 | NA |
| Adenosine | ME281752 | 0.37 | 1.85 | 1.21 | NA |
| Alanine | ME281741 | 0.48 | 1.67 | 1.37 | NA |
| CAR(2:0) | ME281764 | NA | 1.36 | 0.64 | NA |
| Creatinine | ME281746 | NA | 1.24 | 0.76 | NA |
| Pyruvic acid | ME281768 | NA | 1.21 | 0.86 | NA |
| Fructose-1,6-biphosphate | ME281758 | 0.34 | 1.89 | 0.77 | NA |
| Succinic acid | ME281754 | 0.87 | 1.72 | 0.54 | NA |
Factors:
| F1 | Source:Bioengineered human iPS-derived fatty liver tissue-iKD-SIRT1 |
| F2 | Source:Healthy Control Liver Tissue |
| F3 | Source:NASH Liver Tissue from Patient |
| F4 | Source:Negative Control Empty Scaffold |
